Global Bisoprolol Market Growth 2024, Forecast To 2033
7 Nov, 2024
The bisoprolol market has shown strong growth, increasing from $1.84 billion in 2023 to $2 billion in 2024, with a CAGR of 8.6%. This growth is attributed to the rising prevalence of cardiovascular diseases, aging population, greater availability of generic drugs, increased awareness of hypertension management, and higher healthcare expenditures. The market is anticipated to grow to $2.8 billion by 2028, at a CAGR of 8.7%. Growth in the forecast period can be attributed to the rise of cardiovascular specialty clinics, patient support programs, increasing incidences of lifestyle-related diseases, a higher number of clinical trials, and increased funding for cardiovascular health initiatives. Major trends expected in this period include advancements in drug delivery systems, development of patient-centric therapies, integration of AI in drug development, and advancements in cardiovascular diagnostics.
Global Bisoprolol Market Key Driver
The increasing prevalence of hypertension is expected to drive the growth of the bisoprolol market going forward. Hypertension, characterized by consistently elevated blood pressure levels, is increasingly prevalent due to sedentary lifestyles, high obesity rates, and poor dietary choices. Bisoprolol is used to manage hypertension by lowering blood pressure, reducing the workload on the heart, and improving blood flow. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, deaths due to hypertensive diseases accounted for 3.7% in 2022, rising from 3.4% in 2021. Consequently, the increasing prevalence of hypertension will drive growth in the bisoprolol market.
Get A Free Sample Of The Bisoprolol Market ReportGlobal Bisoprolol Market Segments
The bisoprolol market covered in this report is segmented –
1) By Type: Tablet, Capsule
2) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
3) By Application: High Blood Pressure, Coronary Heart Disease, Angina Pectoris, Other Applications
By Geography:The regions covered in the bisoprolol market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the bisoprolol market in 2023.
Major Bisoprolol Industry Players
Merck & Co. Inc., Abbott Healthcare Pvt Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Intas Pharmaceuticals Limited, Cipla Limited, Hikma Pharmaceuticals, Lupin Limited, Dr. Reddy’s Laboratories Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Ipca Laboratories Limited, Medreich Limited, Alembic Pharmaceuticals Limited, Accord Healthcare Limited, Zydus Lifesciences Limited, Zentiva Group, Taj Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Suanfarma, Rusan Healthcare Limited, VHB Lifesciences Limited, Synnat Pharmaceuticals, Vidakem Lifesciences Pvt Ltd., Pluviaendo Pharmaceuticals
Purchase The Global Bisoprolol Market Report Directly And Get A Swift Delivery
Bisoprolol Market Overview
Bisoprolol is a beta-blocker medication that helps manage high blood pressure, heart failure, and chest pain (angina). It works by blocking the effects of adrenaline on the heart, lowering heart rate and blood pressure, which reduces the heart’s workload.
Bisoprolol Global Market Report 2023 provides data on the global bisoprolol market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The bisoprolol market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.